CDKN2A and cancer: Mutations near CDKN2A were particularly associated with diseases of aging (e.g., cancer, atherosclerosis, type 2 diabetes, glaucoma). CDKN2A expression increases with age. Removal of p16+ cells in mouse models increases health span and lifespan.